Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Arch. bronconeumol. (Ed. impr.) ; 53(11): 622-628, nov. 2017. tab
Artigo em Espanhol | IBECS | ID: ibc-168680

RESUMO

Los grupos de control y tratamiento del tabaquismo de ALAT y SEPAR han colaborado para la realización de este documento en el que se da respuesta, siguiendo metodología PICO, a diferentes interrogantes relacionados con la asistencia sanitaria para ayudar a dejar de fumar a los pacientes con EPOC. Sus principales recomendaciones son: a)evidencia moderada y recomendación fuerte para realizar espirometría en pacientes con diagnóstico o en fumadores con alto riesgo de padecer EPOC, como instrumento de motivación, en particular evidenciando la edad pulmonar, y con fines diagnósticos y de búsqueda activa de casos; b)evidencia alta y recomendación fuerte para utilizar asesoramiento conductual intenso y específico y tratamiento farmacológico para ayudar a dejar de fumar a fumadores con EPOC; c)evidencia alta y recomendación fuerte para iniciar intervenciones para ayudar a dejar de fumar a fumadores con EPOC mientras se encuentran hospitalizados mejorando al mantener la intervención tras el alta, y d)evidencia alta y recomendación fuerte para la financiación del tratamiento del tabaquismo en fumadores con EPOC por su impacto sobre la salud y la economía de la salud (AU)


The ALAT and SEPAR Treatment and Control of Smoking Groups have collaborated in the preparation of this document which attempts to answer, by way of PICO methodology, different questions on health interventions for helping COPD patients to stop smoking. The main recommendations are: (I) moderate-quality evidence and strong recommendation for performing spirometry in COPD patients and in smokers with a high risk of developing the disease, as a motivational tool (particularly for showing evidence of lung age), a diagnostic tool, and for active case-finding; (II) high-quality evidence and strong recommendation for using intensive dedicated behavioral counselling and drug treatment for helping COPD patients to stop smoking; (III)high-quality evidence and strong recommendation for initiating interventions for helping COPD patients to stop smoking during hospitalization with improvement when the intervention is prolonged after discharge, and (IV) high-quality evidence and strong recommendation for funding treatment of smoking in COPD patients, in view of the impact on health and health economics (AU)


Assuntos
Humanos , Doença Pulmonar Obstrutiva Crônica/complicações , Tabagismo/epidemiologia , Abandono do Hábito de Fumar/métodos , Espirometria , Testes de Função Respiratória , Guias como Assunto , Oximetria
2.
Arch Bronconeumol ; 53(11): 622-628, 2017 Nov.
Artigo em Inglês, Espanhol | MEDLINE | ID: mdl-28558926

RESUMO

The ALAT and SEPAR Treatment and Control of Smoking Groups have collaborated in the preparation of this document which attempts to answer, by way of PICO methodology, different questions on health interventions for helping COPD patients to stop smoking. The main recommendations are: (i)moderate-quality evidence and strong recommendation for performing spirometry in COPD patients and in smokers with a high risk of developing the disease, as a motivational tool (particularly for showing evidence of lung age), a diagnostic tool, and for active case-finding; (ii)high-quality evidence and strong recommendation for using intensive dedicated behavioral counselling and drug treatment for helping COPD patients to stop smoking; (iii)high-quality evidence and strong recommendation for initiating interventions for helping COPD patients to stop smoking during hospitalization with improvement when the intervention is prolonged after discharge, and (iv)high-quality evidence and strong recommendation for funding treatment of smoking in COPD patients, in view of the impact on health and health economics.


Assuntos
Medicina Baseada em Evidências/métodos , Doença Pulmonar Obstrutiva Crônica/psicologia , Abandono do Hábito de Fumar/psicologia , Fumar/psicologia , Espirometria/psicologia , Biomarcadores , Bupropiona/economia , Bupropiona/uso terapêutico , Ensaios Clínicos como Assunto , Análise Custo-Benefício , Aconselhamento/economia , Aconselhamento/métodos , Humanos , Motivação , Nicotina/economia , Nicotina/uso terapêutico , Agonistas Nicotínicos/economia , Agonistas Nicotínicos/uso terapêutico , Doença Pulmonar Obstrutiva Crônica/fisiopatologia , Ensaios Clínicos Controlados Aleatórios como Assunto , Fumar/tratamento farmacológico , Fumar/economia , Fumar/terapia , Abandono do Hábito de Fumar/economia , Abandono do Hábito de Fumar/métodos , Inquéritos e Questionários , Vareniclina/economia , Vareniclina/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...